Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth
Abstract Background Penfluridol (PF) is an FDA-approved antipsychotic drug that has recently been shown to have anticancer activity. However, the anticancer effects and underlying mechanisms of PF are not well-established in gallbladder cancer (GBC). Methods The anticancer efficacy of PF on GBC was...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2022-07-01
|
| Schriftenreihe: | Cell Communication and Signaling |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s12964-022-00882-8 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
